INFINITY PHARMACEUTICALS INC (INFI)
US45665G3039 - Common Stock
INFINITY PHARMACEUTICALS INC
NASDAQ:INFI (9/13/2023, 7:17:37 PM)
After market: 0.04 0 (-10.51%)0.0447
-0.04 (-46.98%)
Company Profile
Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing novel medicines for people with cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 30 full-time employees. The company went IPO on 2000-07-27. The firm is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma (PI3K-gamma). Its eganelisib clinical development program includes MAcrophage Reprogramming in Immuno-Oncology-3 (MARIO-3), MARIO-275 and MARIO-1. MARIO-3 is a multi-arm Phase II study designed to evaluate eganelisib in the front-line treatment for both metastatic triple-negative breast cancer (TNBC), and renal cell carcinoma (RCC). MARIO-275 is its global, randomized, placebo-controlled Phase II study evaluating the effect of adding eganelisib to nivolumab, also known as Opdivo, in checkpoint-naive advanced urothelial cancer (UC). MARIO-1 is in the Phase I/Ib clinical study.
Company Info
INFINITY PHARMACEUTICALS INC
1100 Massachusetts Avenue, Floor 4
Cambridge MASSACHUSETTS 02138
P: 16174531000.0
CEO: Adelene Q. Perkins
Employees: 30
Website: https://www.infi.com/
INFI News
6 months ago - The Rosen Law Firm, P.A.INFI DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI
6 months ago - NewMediaWireINFI DEADLINE TOMORROW: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFISearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
6 months ago - Bragar Eagel & Squire, P.C.INFINITY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
6 months ago - THE ROSEN LAW FIRM, P. A.INFI DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)...
6 months ago - NewMediaWireINFI DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFISearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
6 months ago - NewMediaWireINFI DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFISearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
INFI Twits
Here you can normally see the latest stock twits on INFI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
